Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation TCT 2023

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

Presenter: Ndausung Udongwo

October 26, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

Presenter: Dena Hayes

October 26, 2023

Presentation TCT 2023

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Presenter: Michael Bashline

October 26, 2023

Presentation TCT 2023

TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Presenter: Muhammad Junaid Ahsan

October 26, 2023

Presentation THT 2023

Applications of Gene Therapy in Cardiomyopathies (TBD)

Presenter: Eric Adler

March 20, 2023

Presentation THT 2022

Featured Lecture: Medical Therapies for Amyloid

Presenter: Matthew Maurer

February 01, 2022

Presentation THT 2022

Percutaneous and Surgical Approaches for Hypertrophic Obstructive Cardiomyopathies

Presenter: Srihari Naidu

February 01, 2022

Presentation THT 2022

Novel Drug Therapies for HCM

Presenter: Carolyn Ho

February 01, 2022

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Presentation THT 2022

The Role of Genetic Testing in Heart Failure (When Should You Order It)

Presenter: W. H. Wilson Tang

February 01, 2022

Presentation ECHO 2014

Systolic Heart Failure: Review of Cardiomyopathies

Presenter: Michael H. Picard

April 10, 2014

Advertisement

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

TCT 306: Impact of Cardiac Amyloidosis in Patients with Severe Aortic Stenosis Undergoing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Applications of Gene Therapy in Cardiomyopathies (TBD)

Featured Lecture: Medical Therapies for Amyloid

Percutaneous and Surgical Approaches for Hypertrophic Obstructive Cardiomyopathies

Novel Drug Therapies for HCM

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

The Role of Genetic Testing in Heart Failure (When Should You Order It)

Systolic Heart Failure: Review of Cardiomyopathies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content